Why CEOs Must Wake Up To Sleep Deprivation In The Workplace [Forbes]
ResMed Inc. (RMD)
Last resmed inc. earnings: 4/30 04:05 pm
Check Earnings Report
US:NYSE Investor Relations:
investors.resmed.com/investor-relations/default.aspx
Company Research
Source: Forbes
From decision-making to emotional intelligence, focus to physical vibrancy—sleep is the invisible infrastructure holding everything together. Yet many employees and high-ranking leaders are operating on a harmful deficit. We're in the midst of a global sleep deprivation crisis. According to , 62% of the world's population fails to get the recommended minimum of seven hours per night. It's not just about feeling tired—chronic sleep deprivation is linked to a 29% increase in mortality risk, according to a study of nearly 47,000 Americans. Like any significant health or lifestyle issue, what happens at home isn't self-contained. Sleep-deprived employees bring their exhaustion straight into the workplace. And the consequences are costly. The Cost Of S
Read more
Impact Snapshot
Event Time:
RMD
Last Price
Price Change
Price Change%
Volume Shares
Max Up
Max Down
%
Volume Ratio
Performance Comparison
Updated
|
Event Day
Stock performance from the time of news release until the following 4pm ET market close
|
Last price at news event
|
Since Event
Multi-day stock performance from the time of the news release
|
|---|---|---|
|
EVENT DAY
Stock performance from the time of news release until the following 4pm ET market close
|
LAST
PRICE AT NEWS EVENT |
SINCE EVENT
Multi-day stock performance from the time of the news release
|
| Last Price | ||
| VWAP | ||
|
High:
|
Max Up |
High:
|
|
Low:
|
Max Down |
Low:
|
|
%
|
Post news range |
%
|
|
|
Price change |
|
|
|
Price Change Percentage |
|
|
|
S&P 500 (SPX) |
|
|
%
|
Volume ratio |
%
|
| Volume | ||
| Ticks | ||
|
|
Avg transaction size |
|
Don't Miss Out On The Next BIG Stock Move
Event day
Event Day Chart will not be displayed beyond 90-day period of the event
Performance since event
Time And Velocity Analysis
Be the first to know
Opt in for alerts from News Quantifed
Sign Up Today
Opt-in for
RMD alerts
Learn More With NQ
Reading the Impact Report
Help Me Understand This Data
Help Me Understand This Data
How NQ Works
What is news-based trading?
And why is it so successful?
And why is it so successful?
Movers & Shakers
The biggest gainers and losers and WHY it moved
RMD alerts
High impacting ResMed Inc. news events
Weekly update
A roundup of the hottest topics
RMD
News
- ResMed Inc. (NYSE: RMD) had its price target raised by analysts at Royal Bank of Canada from $247.00 to $255.00. They now have a "sector perform" rating on the stock.MarketBeat
- ResMed Inc. (NYSE: RMD) had its price target lowered by analysts at UBS Group AG from $290.00 to $285.00. They now have a "buy" rating on the stock.MarketBeat
- ResMed Inc. (NYSE: RMD) had its price target raised by analysts at JPMorgan Chase & Co. from $286.00 to $290.00. They now have an "overweight" rating on the stock.MarketBeat
- ResMed Inc. (NYSE: RMD) had its price target lowered by analysts at Piper Sandler from $260.00 to $248.00. They now have a "neutral" rating on the stock.MarketBeat
- ResMed Inc. (NYSE: RMD) was given a new $274.00 price target on by analysts at KeyCorp.MarketBeat
RMD
Earnings
- 4/23/25 - Beat
RMD
Sec Filings
- 4/24/25 - Form 10-Q
- 4/23/25 - Form 8-K
- 4/10/25 - Form 4
- RMD's page on the SEC website